Without the NHS, There Would Be 70,000 Fewer Deaths.

SARS-CoV-2 Continues To Weaken. Despite the propaganda, mutant killer of death and apparent overwhelmed hospitals, SARS-CoV-2 continues to attenuate, or weaken, globally. We monitor the data constantly and since August have been highlighting that both active and closed cases have been attenuating and continue to attenuate. As we illustrated at the end of August, Active […]

Read More…


Antivirals – lessons from the ‘flu jab’.

That Time Of Year Again. If you have read the previous two articles then you will know the main differences between a vaccine and an antiviral, and why Remdesivir is not an effective antiviral for just about anyone with COVID-19. We have highlighted that antivirals have a pretty patchy record when it comes to their […]

Read More…


Does Ibuprofen make SARS-CoV-2 better or worse? Here are two strong reasons not to take it.

Background Back in April we first wrote about a possible connection between the increasingly above-average mortality rates in European countries and their widespread use of non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen. We raised the question as to whether the cyclooxygenase (COX) enzyme inhibitor function of NSAIDs either intefered with or amplified the angiotensin-converting enzyme […]

Read More…


Why is Europe now doing even worse?

Analysing the latest figures from Johns Hopkins Coronavirus Resource Center, the worldwide average for deaths per 1million population is now 10.5, which is 0.00105%. Compare this to the worldwide average death rate for seasonal or winter flu of 0.1% (source: World Health Organisation). The COVID-19 death rate is currently 95x lower than seasonal or winter […]

Read More…